Tegonat 15mg Capsule

About

Tegonat 15mg Capsule is an antineoplastic agent, likely a fluoropyrimidine derivative or a similar antimetabolite, utilized in the treatment of various solid tumors. This class of drugs typically functions by interfering with critical cellular processes, particularly DNA and RNA synthesis, which are essential for cell proliferation and survival. By acting as false building blocks or inhibiting key enzymes involved in nucleic acid metabolism, Tegonat disrupts the normal replication and repair mechanisms of rapidly dividing cancer cells. This disruption ultimately leads to DNA damage, cell cycle arrest, and programmed cell death (apoptosis), thereby inhibiting tumor growth and progression. Its oral formulation provides a convenient administration route for patients undergoing long-term chemotherapy regimens, often as part of a multi-drug protocol to enhance efficacy and overcome resistance mechanisms.

Uses

• Colorectal cancer
• Gastric cancer
• Pancreatic cancer
• Breast cancer (adjuvant therapy)

Directions For Use

Take orally with water, usually after meals. Follow the prescribed dosage and schedule strictly.

Benefits

• Inhibits cancer cell growth
• Oral administration for convenience
• Can be used in combination therapies
• May improve disease-free survival
• Reduces tumor burden
• Potential for improved overall survival

Side Effects

• Nausea
• Vomiting
• Diarrhea
• Stomatitis (mouth sores)
• Hand-foot syndrome
• Fatigue
• Myelosuppression (low blood counts)
• Abdominal pain
• Anorexia
• Hair loss (alopecia)
• Skin rash
• Dehydration

Safety Measures

• Alcohol - Alcohol consumption should be avoided or minimized as it may exacerbate gastrointestinal side effects and liver toxicity.
• Pregnancy - Tegonat is contraindicated in pregnancy due to its teratogenic potential; effective contraception is essential during treatment.
• Breastfeeding - Breastfeeding is not recommended during treatment and for a period after due to potential harm to the infant.
• Liver - Use with caution in patients with hepatic impairment; liver function tests should be monitored regularly.
• Kidney - Dose adjustments may be necessary for patients with renal impairment; monitor kidney function closely.
• Lung - Patients should be monitored for new or worsening respiratory symptoms, as rare cases of pulmonary toxicity have been reported.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.